Nemagen
1 known investors
NemaGen Discoveries develops first-in-class therapies targeting mast cell-related diseases and chronic inflammation by leveraging insights from studying the body's natural inflammatory response to parasitic infections.
Founders & leadership
M
MarkAssociate Professor in the Department of Medicine and the Center for Immunity and Inflammation at Rutgers New Jersey Medical School
M
MartinChief Executive Officer
Investors · 1
Frequently asked questions
- What does Nemagen do?
- NemaGen Discoveries develops first-in-class therapies targeting mast cell-related diseases and chronic inflammation by leveraging insights from studying the body's natural inflammatory response to parasitic infections.
- Who founded Nemagen?
- Nemagen was founded by Mark.
- Who are Nemagen's investors?
- Nemagen's investors include Foundation Venture Capital Group, LLC.